Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA grants fast track designation to solithromycin for CABP

Aug. 20, 2015

Vical's VL-2397 gets FDA QIDP designation

Aug. 20, 2015

Bavarian Nordic initiates first-in-human study of RSV vaccine

Aug. 19, 2015

FDA awards QIDP status to Matinas BioPharma's encochleated amphotericin B

Aug. 19, 2015

Enanta Pharmaceuticals designs anti-HCV agents

Aug. 19, 2015

CSIR scientists develop agents for treatment of tuberculosis

Aug. 18, 2015

Roche describes HBsAg secretion inhibitors

Aug. 18, 2015

FDA grants fast track designation to CF-301

Aug. 18, 2015

Redx Pharma patents antibacterial agents

Aug. 14, 2015

Roche patents new anti-RSV compounds

Aug. 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...